Are we satisfied with the rate of drug development? Are we happy with the drugs that come to market? Are we getting our money's worth in spending for basic biomedical research? In Translational Systems Biology, Drs. Yoram Vodovotz and Gary An address these questions by providing a foundational description the barriers facing biomedical research today and the immediate future, and how these barriers could be overcome through the adoption of a robust and scalable approach that will form the underpinning of biomedical research for the future. By using a combination of essays providing the intellectual basis of the Translational Dilemma and reports of examples in the study of inflammation, the content of Translational Systems Biology will remain relevant as technology and knowledge advances bring broad translational applicability to other diseases. Translational systems biology is an integrated, multi-scale, evidence-based approach that combines laboratory, clinical and computational methods with an explicit goal of developing effective means of control of biological processes for improving human health and rapid clinical application. This comprehensive approach to date has been utilized for in silico studies of sepsis, trauma, hemorrhage, and traumatic brain injury, acute liver failure, wound healing, and inflammation. * Provides an explicit, reasoned, and systematic approach to dealing with the challenges of translational science across disciplines* Establishes the case for including computational modeling at all stages of biomedical research and healthcare delivery, from early pre-clinical studies to long-term care, by clearly delineating efficiency and costs saving important to business investment* Guides readers on how to communicate across domains and disciplines, particularly between biologists and computational researchers, to effectively develop multi- and trans-disciplinary research teams
"synopsis" may belong to another edition of this title.
Yoram Vodovotz, Ph.D., is currently the President of the Society for Complexity in Acute Illness. His research interests include the biology of acute inflammation in shock states, chronic inflammatory diseases, wound healing, malaria, and restenosis. His work utilizes mathematical modeling to unify and gain insight into the biological interactions that characterize these inflammatory conditions. As the Director of the Center for Inflammation and Regenerative Modeling (CIRM) at the University of Pittsburgh's McGowan Institute for Regenerative Medicine, he has been involved in the mathematical modeling of acute inflammatory states (e.g. septic or hemorrhagic shock, wound healing), including cellular and physiological elements, as part of a large, interdisciplinary collaborative team. He is also a co-founder of Immunetrics, Inc., a company that is commercializing this mathematical modeling work. Gary An is a trauma/critical care surgeon at The University of Chicago engaged in translational computational research. His work on system-level simulations of trauma and sepsis led him to a more general concern about the ability of biomedical researchers to represent their knowledge and hypotheses in a form that can be "executed, so that the dynamic consequences of their hypotheses can be seen and evaluated. He is the author of over 59 primary papers and book chapters, is a Senior Fellow of the University of Chicago Computation Institute and current president of the Swarm Development Group for simulation software.
Are we satisfied with the rate of drug development? Are we happy with the drugs that come to market? Are we getting our money’s worth in spending for basic biomedical research?
In Translational Systems Biology, Drs. Yoram Vodovotz and Gary An address these questions by providing a foundational description the barriers facing biomedical research today and the immediate future, and how these barriers could be overcome through the adoption of a robust and scalable approach that will form the underpinning of biomedical research for the future. By using a combination of essays providing the intellectual basis of the Translational Dilemma and reports of examples in the study of inflammation, the content of Translational Systems Biology will remain relevant as technology and knowledge advances bring broad translational applicability to other diseases.
Translational systems biology is an integrated, multi-scale, evidence-based approach that combines laboratory, clinical and computational methods with an explicit goal of developing effective means of control of biological processes for improving human health and rapid clinical application. This comprehensive approach to date has been utilized for in silico studies of sepsis, trauma, hemorrhage, and traumatic brain injury, acute liver failure, wound healing, and inflammation.
"About this title" may belong to another edition of this title.
£ 3.69 shipping within U.S.A.
Destination, rates & speedsSeller: Biblio Pursuit, Lenhartsville, PA, U.S.A.
Hardcover. Condition: As New. 1st Edition. As New! No Markings, No Underlining, No Highlighting, Seller Inventory # 058438
Quantity: 3 available
Seller: ThriftBooks-Dallas, Dallas, TX, U.S.A.
Hardcover. Condition: As New. No Jacket. Pages are clean and are not marred by notes or folds of any kind. ~ ThriftBooks: Read More, Spend Less 1.01. Seller Inventory # G012397884XI2N00
Quantity: 1 available
Seller: Brook Bookstore On Demand, Napoli, NA, Italy
Condition: new. Questo è un articolo print on demand. Seller Inventory # fa602c35d1d042b69c2cd67e12e82514
Quantity: Over 20 available
Seller: Chiron Media, Wallingford, United Kingdom
Hardcover. Condition: New. Seller Inventory # 6666-ELS-9780123978844
Quantity: Over 20 available
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. pp. 352. Seller Inventory # 322589742
Quantity: 3 available
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. pp. 352. Seller Inventory # 26323873777
Quantity: 3 available
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Hardback. Condition: New. New copy - Usually dispatched within 4 working days. 737. Seller Inventory # B9780123978844
Quantity: Over 20 available
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. 1st edition. 162 pages. 11.00x8.50x0.75 inches. In Stock. Seller Inventory # __012397884X
Quantity: 2 available
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. pp. 352. Seller Inventory # 18323873787
Quantity: 3 available
Seller: Rheinberg-Buch Andreas Meier eK, Bergisch Gladbach, Germany
Buch. Condition: Neu. Neuware -Are we satisfied with the rate of drug development Are we happy with the drugs that come to market Are we getting our money's worth in spending for basic biomedical research In Translational Systems Biology, Drs. Yoram Vodovotz and Gary An address these questions by providing a foundational description the barriers facing biomedical research today and the immediate future, and how these barriers could be overcome through the adoption of a robust and scalable approach that will form the underpinning of biomedical research for the future. By using a combination of essays providing the intellectual basis of the Translational Dilemma and reports of examples in the study of inflammation, the content of Translational Systems Biology will remain relevant as technology and knowledge advances bring broad translational applicability to other diseases. Translational systems biology is an integrated, multi-scale, evidence-based approach that combines laboratory, clinical and computational methods with an explicit goal of developing effective means of control of biological processes for improving human health and rapid clinical application. This comprehensive approach to date has been utilized for in silico studies of sepsis, trauma, hemorrhage, and traumatic brain injury, acute liver failure, wound healing, and inflammation. 178 pp. Englisch. Seller Inventory # 9780123978844
Quantity: 2 available